Skip to main content
Top
Published in: BMC Cancer 1/2019

Open Access 01-12-2019 | Lipoma | Case report

Metachronous ovarian endometrioid carcinomas in a patient with a PTEN variant: case report of incidentally detected Cowden syndrome

Authors: Hiroyuki Matsubayashi, Satomi Higashigawa, Yoshimi Kiyozumi, Yasue Horiuchi, Yasuyuki Hirashima, Nobuhiro Kado, Masato Abe, Takuma Ohishi, Sumiko Ohnami, Kenichi Urakami, Ken Yamaguchi

Published in: BMC Cancer | Issue 1/2019

Login to get access

Abstract

Background

Somatic PTEN mutation occurs in a proportion of ovarian endometrioid carcinomas. However, these cancers have seldom been reported in diseases associated with germline PTEN variants, such as Cowden syndrome (CS).

Case presentation

The present case was a 39-year-old woman with a left ovarian carcinoma who demonstrated a germline splice variant of PTEN (c.1026 + 1G > T) following genome-wide whole exome sequencing of her germline DNA. Histology of her resected tumor revealed endometrioid carcinoma of the same type as a right ovarian cancer resected eight years previously. These tumors showed null immunostaining for PTEN. She was genetically diagnosed with CS. Despite her clinical examinations had demonstrated several characteristic findings of CS, including mammary fibroma, esophageal and skin papilloma, colonic hamartoma, uterine myoma, and lipoma, the clinicians could not approach this diagnosis.

Conclusion

Ovarian endometrioid carcinoma is generally thought to develop from endometrial tissue menstruated from the uterus and implanted on the ovary. To date, ovarian cancers have not been listed as CS-related cancers; however, ovarian endometrioid cancer can have a potential association with CS in endometriosis cases.
Literature
2.
go back to reference Kurman RJ, Shih IM. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol. 2010;34:433–43.CrossRef Kurman RJ, Shih IM. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol. 2010;34:433–43.CrossRef
3.
go back to reference Urakami K, Shimoda Y, Ohshima K, et al. Next generation sequencing approach for detecting 491 fusion genes from human cancer. Biomed Res. 2016;37:51–62.CrossRef Urakami K, Shimoda Y, Ohshima K, et al. Next generation sequencing approach for detecting 491 fusion genes from human cancer. Biomed Res. 2016;37:51–62.CrossRef
4.
go back to reference Uemura S, Matsubayashi H, Kiyozumi Y, et al. Pancreatic adenocarcinoma with a germline PTEN p.Arg234Gln mutation. Familial Cancer. 2018;17:255–9.CrossRef Uemura S, Matsubayashi H, Kiyozumi Y, et al. Pancreatic adenocarcinoma with a germline PTEN p.Arg234Gln mutation. Familial Cancer. 2018;17:255–9.CrossRef
5.
go back to reference Tatton-Brown K, Loveday C, Yost S, et al. Mutations in epigenetic regulation genes are a major cause of overgrowth with intellectual disability. Am J Hum Genet. 2017;100:725–36.CrossRef Tatton-Brown K, Loveday C, Yost S, et al. Mutations in epigenetic regulation genes are a major cause of overgrowth with intellectual disability. Am J Hum Genet. 2017;100:725–36.CrossRef
6.
go back to reference Tan MH, Mester JL, Ngeow J, et al. Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res. 2012;18:400–7.CrossRef Tan MH, Mester JL, Ngeow J, et al. Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res. 2012;18:400–7.CrossRef
7.
go back to reference Govatati S, Kodati VL, Deenadayal M, et al. Mutations in the PTEN tumor gene and risk of endometriosis: a case-control study. Hum Reprod. 2014;29:324–36.CrossRef Govatati S, Kodati VL, Deenadayal M, et al. Mutations in the PTEN tumor gene and risk of endometriosis: a case-control study. Hum Reprod. 2014;29:324–36.CrossRef
8.
go back to reference Xu B, Hamada S, Kusuki I, et al. Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis. Gynecol Oncol. 2011;120:239–46.CrossRef Xu B, Hamada S, Kusuki I, et al. Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis. Gynecol Oncol. 2011;120:239–46.CrossRef
9.
go back to reference Sato N, Tsunoda H, Nishida M, et al. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res. 2000;60:7052–6.PubMed Sato N, Tsunoda H, Nishida M, et al. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res. 2000;60:7052–6.PubMed
10.
go back to reference Kolasa IK, Rembiszewska A, Janiec-Jankowska A, et al. PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations. Gynecol Oncol. 2006;103:692–7.CrossRef Kolasa IK, Rembiszewska A, Janiec-Jankowska A, et al. PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations. Gynecol Oncol. 2006;103:692–7.CrossRef
11.
go back to reference Yauy K, Imbert-Bouteille M, Bubien V, et al. Ovarian clear cell carcinoma in Cowden syndrome. J Natl Compr Cancer Netw. 2019;17:7–11.CrossRef Yauy K, Imbert-Bouteille M, Bubien V, et al. Ovarian clear cell carcinoma in Cowden syndrome. J Natl Compr Cancer Netw. 2019;17:7–11.CrossRef
12.
go back to reference Fadare O, Parkash V. Pathology of Endometrioid and clear cell carcinoma of the ovary. Surg Pathol Clin. 2019;12:529–64.CrossRef Fadare O, Parkash V. Pathology of Endometrioid and clear cell carcinoma of the ovary. Surg Pathol Clin. 2019;12:529–64.CrossRef
13.
go back to reference Bubien V, Bonnet F, Brouste V, et al. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome. J Med Genet. 2013;50:255–63.CrossRef Bubien V, Bonnet F, Brouste V, et al. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome. J Med Genet. 2013;50:255–63.CrossRef
14.
go back to reference Cho MY, Kim HS, Eng C, et al. First report of ovarian dysgerminoma in Cowden syndrome with germline PTEN mutation and PTEN-related 10q loss of tumor heterozygosity. Am J Surg Pathol. 2008;32:1258–64.CrossRef Cho MY, Kim HS, Eng C, et al. First report of ovarian dysgerminoma in Cowden syndrome with germline PTEN mutation and PTEN-related 10q loss of tumor heterozygosity. Am J Surg Pathol. 2008;32:1258–64.CrossRef
15.
go back to reference Papageorgiou T, Stratakis CA. Ovarian tumors associated with multiple endocrine neoplasias and related syndromes (carney complex, Peutz-Jeghers syndrome, von Hippel-Lindau disease, Cowden's disease). Int J Gynecol Cancer. 2002;12:337–47.CrossRef Papageorgiou T, Stratakis CA. Ovarian tumors associated with multiple endocrine neoplasias and related syndromes (carney complex, Peutz-Jeghers syndrome, von Hippel-Lindau disease, Cowden's disease). Int J Gynecol Cancer. 2002;12:337–47.CrossRef
Metadata
Title
Metachronous ovarian endometrioid carcinomas in a patient with a PTEN variant: case report of incidentally detected Cowden syndrome
Authors
Hiroyuki Matsubayashi
Satomi Higashigawa
Yoshimi Kiyozumi
Yasue Horiuchi
Yasuyuki Hirashima
Nobuhiro Kado
Masato Abe
Takuma Ohishi
Sumiko Ohnami
Kenichi Urakami
Ken Yamaguchi
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2019
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-019-6272-2

Other articles of this Issue 1/2019

BMC Cancer 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine